Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rury Holman

Emeritus Professor of Diabetic Medicine

  • Former Diabetes Trials Unit Director
  • NIHR Senior Investigator
  • Honorary Consultant Physician

The DTU is a fully registered UKCRC Clinical Trials Unit and a founder member of OCDEM. It is one of only a handful of Academic Research Organisations (AROs) worldwide that specialise in performing diabetes-related mega trials. The DTU designs, runs and analyses large-scale Phase III & IV interventional clinical outcome trials nationally and internationally, often in collaboration with other AROs and pharmaceutical companies. Currently the DTU is undertaking 4 large-scale cardiovascular outcome trials in 40 countries, multiple translational trials, holds grants in excess of £60M and has a regional coordinating centre in Beijing, China.

The DTU Translational Trials Group evaluates novel treatments and devices for the therapy of diabetes trials and undertakes research into potential new therapeutic agents in Phase IIa/b trials. The DTU also undertakes major modelling and statistical programmes to utilise fully the data available from its many studies with a particular emphasis on modelling diabetes and cardiovascular disease processes. The DTU Informatics Group designs and maintains the specialist departmental software, the automated data handling facilities and the in-house electronic clinical trials management systems.